Login / Signup

High-dose melphalan-autologous hematopoietic cell transplantation in systemic AL amyloidosis following daratumumab-based frontline therapy.

George S MellgardDivaya BhutaniMarkus Y MaparaMathew S MaurerJai RadhakrishnanSuzanne LentzschRajshekhar Chakraborty
Published in: Bone marrow transplantation (2024)
Keyphrases
  • high dose
  • multiple myeloma
  • stem cell transplantation
  • low dose
  • cell therapy
  • bone marrow
  • platelet rich plasma
  • stem cells
  • mesenchymal stem cells